Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy

Trial Profile

Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Dexrazoxane (Primary) ; Doxorubicin
  • Indications Cardiomyopathies; Heart failure
  • Focus Pharmacodynamics
  • Acronyms HEART
  • Most Recent Events

    • 05 Apr 2016 Trial protocol (Treatment arms, study design, endpoints) amended as reported by ClinicalTrials.gov record.
    • 22 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top